Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
PALO ALTO,Calif.,Nov. 4,2024--Branch,the leading linking and measurement partner for growth-focused teams,in collaboration with Martechvibe,is excited to announce the release of its latest report,The
Taking place on Abu Dhabi\'sCorniche from November 1st to 3rd,\'Building bridges for the future UAE & China\' will host a series of interactive workshops,live performances,cultural displays,and cu
HONG KONG,Nov. 4,2024-- As autumn settles in and temperatures begin to drop,many individuals embrace outdoor activities such as running,cycling,and hiking,delighting in the beauty of nature. However,
MELBOURNE,Australia,Nov. 4,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today welcomes the announcement by the United States (U.S.) Centers for Medicare & Medicaid Services (
SINGAPORE,Nov. 4,2024-- Xtend,a leading AI-powered digital marketing company,has announced record financial results for the first half of the 2024/2025 fiscal year,achieving a remarkable 113% increase
HONG KONG,Oct. 31,2024-- Global innovative technology brandTECNO today shared that its innovative TECNO Pocket Go has been listed as one of TIME\'s Best Inventions of 2024 by TIME.
Sophia,the local humanoid,shines at the Summit,sparking excitement for Hong Kong\'s smart city future.
BEIJING,Oct. 31,2024-- Wednesday marked the 15th anniversary of theChiNext board,a Nasdaq-style board for growth enterprises in China,which opened for trading on October 30,2009. After 15 years of rap
This approval marks the second international marketing authorization forsugemalimab outside of China,following its recent approval by the European Commission.
BOSTON,Oct. 31,2024-- In a remarkable development for cancer research,patients with advanced-stage cancer have benefited fromSUPLEXA,a personalized treatment that trains the patient\'s own immune cel
© OfficialAffairs
